1. Home
  2. PROK vs OFLX Comparison

PROK vs OFLX Comparison

Compare PROK & OFLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • OFLX
  • Stock Information
  • Founded
  • PROK 2015
  • OFLX 1975
  • Country
  • PROK United States
  • OFLX United States
  • Employees
  • PROK N/A
  • OFLX N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • OFLX Industrial Specialties
  • Sector
  • PROK Health Care
  • OFLX Industrials
  • Exchange
  • PROK Nasdaq
  • OFLX Nasdaq
  • Market Cap
  • PROK 384.2M
  • OFLX 344.9M
  • IPO Year
  • PROK N/A
  • OFLX 2005
  • Fundamental
  • Price
  • PROK $2.35
  • OFLX $33.00
  • Analyst Decision
  • PROK Buy
  • OFLX
  • Analyst Count
  • PROK 5
  • OFLX 0
  • Target Price
  • PROK $6.25
  • OFLX N/A
  • AVG Volume (30 Days)
  • PROK 3.3M
  • OFLX 25.4K
  • Earning Date
  • PROK 08-12-2025
  • OFLX 07-30-2025
  • Dividend Yield
  • PROK N/A
  • OFLX 4.14%
  • EPS Growth
  • PROK N/A
  • OFLX N/A
  • EPS
  • PROK N/A
  • OFLX 1.69
  • Revenue
  • PROK $527,000.00
  • OFLX $100,700,000.00
  • Revenue This Year
  • PROK $105.79
  • OFLX N/A
  • Revenue Next Year
  • PROK N/A
  • OFLX N/A
  • P/E Ratio
  • PROK N/A
  • OFLX $20.27
  • Revenue Growth
  • PROK N/A
  • OFLX N/A
  • 52 Week Low
  • PROK $0.46
  • OFLX $28.12
  • 52 Week High
  • PROK $7.13
  • OFLX $57.81
  • Technical
  • Relative Strength Index (RSI)
  • PROK 43.77
  • OFLX 48.93
  • Support Level
  • PROK $2.16
  • OFLX $31.45
  • Resistance Level
  • PROK $2.46
  • OFLX $34.44
  • Average True Range (ATR)
  • PROK 0.34
  • OFLX 1.63
  • MACD
  • PROK -0.16
  • OFLX 0.11
  • Stochastic Oscillator
  • PROK 7.14
  • OFLX 60.40

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

About OFLX Omega Flex Inc.

Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.

Share on Social Networks: